date,title,source
Oct-23-18,Imprimis Pharmaceuticals Subsidiary Melt Pharmaceuticals Initiates Clinical Development Program for its Patented Non-Opioid and Non-Invasive MK Melt Conscious Sedation Drug Candidate,GlobeNewswire
Nov-06-18,"Imprimis Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 13, 2018",GlobeNewswire
Nov-13-18,Imprimis: 3Q Earnings Snapshot,Associated Press
Nov-13-18,Imprimis Pharmaceuticals Announces Third Quarter 2018 Results,GlobeNewswire
Nov-14-18,4 Healthcare Stocks Investors Should Get Familiar With,ACCESSWIRE
Nov-16-18,Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloittes 2018 Technology Fast 500,GlobeNewswire
Nov-19-18,4 Healthcare Stocks Taking a New Approach to Growth Trends,ACCESSWIRE
